迷你神经超声学有助于区分多系统性缩与其他帕金森综合征
Kazumasa Oura1, Takashi Yamaguchi1, Ryota Nozaki1
1Division of Neurology and Gerontology, Department of Internal Medicine, School of Medicine Iwate Medical University Morioka Japan.
Movement disorders clinical practice
|October 23, 2023
概括
神经超声波显示在区分多重系统缩 (MSA) 和其他帕金森综合征方面具有前途. 超声波上较小的迷走神经尺寸可能表明MSA,有助于诊断.
科学领域:
- 神经学 神经学
- 医疗成像医学成像
- 诊断技术 诊断技术
背景情况:
- 从其他帕金森综合征区分多重系统缩 (MSA) 是一个重要的临床挑战.
- 准确的诊断对于适当的患者管理和治疗策略至关重要.
研究的目的:
- 调查迷走神经超声波在区分MSA与其他帕金森综合征中的有用性.
- 为了评估迷走神经横截面积测量的诊断性能.
主要方法:
- 一项横截面的观察性研究包括85名患有新发帕金森症的成年患者.
- 使用12MHz超声波测量双边迷走神经的截面面积.
- 数据是在2020年6月至2022年12月期间收集的.
主要成果:
- 与其他帕金森综合征患者相比,MSA患者的双边迷走神经较小.
- 用于区分MSA的接收器操作特征曲线 (AUC) 下的面积为0.79 (右) 和0.74 (左).
- 特定的截止值显示了MSA诊断的不同程度的灵敏度,特异性和预测值.
结论:
- 神经超声学似乎是一个潜在的非侵入性工具,用于区分MSA与其他帕金森综合征.
- 进一步的研究可能会验证这些发现,并建立用于MSA诊断的标准化超声波协议.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
924
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
924
Ultrasonography
4.5K
Ultrasonography is an imaging technique that uses high-frequency sound waves to visualize the body's internal structures. It is a non-invasive and safe procedure that does not involve the use of ionizing radiation, making it widely used in various medical fields. Ultrasonography is used to study heart function, blood flow in the neck or extremities, certain conditions such as gallbladder disease, and fetal growth and development.
During an ultrasonography procedure, a handheld device called...
During an ultrasonography procedure, a handheld device called...
4.5K
Parkinson's Disease: Overview
567
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
567
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
14
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
14
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Cardiovascular System Abnormal Findings I: Inspection and Palpation
416
In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
Abnormal findings observed during an inspection
416


